World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
67
Citations
14964
World Ranking
2681
National Ranking
1283

Overview

Ted M. Ross is affiliated with the University of Georgia in the United States. Their research primarily focuses on medicine and immunology and microbiology, with a substantial number of publications in these fields.

The scientist's work includes significant contributions to epidemiology, immunology, infectious diseases, molecular biology, and radiology, nuclear medicine, and imaging. Their main topics of study involve influenza virus research, respiratory viral infections, SARS-CoV-2 and COVID-19 research, immune response and inflammation, monoclonal and polyclonal antibodies, vaccines and immunoinformatics approaches, and immune cell function and interaction.

Frequent publication venues for Ted M. Ross include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Vaccine
  • Journal of Virology
  • Vaccines
  • Frontiers in Immunology

Frequent co-authors in their research are:

  • Michael A. Carlock
  • Giuseppe A. Sautto
  • Eric M. Bachelder
  • Kristy M. Ainslie
  • James D. Allen

Selected recent papers authored or co-authored by Ted M. Ross include:

  • Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection (2021, Cell)
  • Extremely potent human monoclonal antibodies from COVID-19 convalescent patients (2021, Cell)
  • De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2 (2020, Science)
  • Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools (2020, Frontiers in Immunology)
  • Development and deployment of COVID-19 vaccines for those most vulnerable (2021, Science Translational Medicine)

Best Publications

  • Critical Role of IL-17RA in Immunopathology of Influenza Infection

    Christopher R. Crowe;Kong Chen;Derek A. Pociask;John F. Alcorn

  • Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein.

    Ted M. Ross;Alp E. Oran;Bryan R. Cullen

  • Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection.

    Emma S. Winkler;Pavlo Gilchuk;Jinsheng Yu;Adam L. Bailey

  • Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.

    Rick A. Bright;Donald M. Carter;Shannon Daniluk;Franklin R. Toapanta

  • C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge.

    Ted M. Ross;Yan Xu;Rick A. Bright;Harriet L. Robinson

  • Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination

    Jiwon Lee;Daniel R. Boutz;Veronika Chromikova;M. Gordon Joyce

  • Impaired immune responses in the lungs of aged mice following influenza infection

    Franklin R Toapanta;Franklin R Toapanta;Ted M Ross

  • Cross-Clade Protective Immune Responses to Influenza Viruses with H5N1 HA and NA Elicited by an Influenza Virus-Like Particle

    Rick A. Bright;Donald M. Carter;Corey J. Crevar;Franklin R. Toapanta

  • Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season.

    Benjamin S. Chambers;Kaela Parkhouse;Ted M. Ross;Kevin Alby

  • A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets.

    Brendan M. Giles;Ted M. Ross

  • Dengue virus and the host innate immune response

    Naoko Uno;Ted M. Ross

  • Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013–2014 influenza season

    Susanne L. Linderman;Benjamin S. Chambers;Seth J. Zost;Kaela Parkhouse

  • Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses

    Donald M. Carter;Christopher A. Darby;Bradford C. Lefoley;Corey J. Crevar

  • Towards a universal influenza vaccine: different approaches for one goal

    Giuseppe A. Sautto;Greg A. Kirchenbaum;Ted M. Ross

  • Immune history shapes specificity of pandemic H1N1 influenza antibody responses

    Yang Li;Jaclyn L. Myers;David L. Bostick;Colleen B. Sullivan

  • Extremely potent human monoclonal antibodies from COVID-19 convalescent patients.

    Emanuele Andreano;Emanuele Nicastri;Ida Paciello;Piero Pileri

  • H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluation.

    James D. Allen;Ted M. Ross

  • H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.

    Kutubuddin Mahmood;Rick A. Bright;Nutan Mytle;Donald M. Carter

  • Intranasal Antibody Gene Transfer in Mice and Ferrets Elicits Broad Protection Against Pandemic Influenza

    Maria P. Limberis;Virginie S. Adam;Gary Wong;Gary Wong;Jason Gren;Jason Gren

  • De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2

    Thomas W. Linsky;Renan Vergara;Nuria Codina;Jorgen W. Nelson

  • Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d.

    Thomas D. Green;David C. Montefiori;Ted M. Ross

Frequent Co-Authors

Clayton A. Wiley
Clayton A. Wiley University of Pittsburgh
Elodie Ghedin
Elodie Ghedin National Institutes of Health
Anne S. De Groot
Anne S. De Groot University of Georgia
Richard K. Zimmerman
Richard K. Zimmerman University of Pittsburgh
Scott E. Hensley
Scott E. Hensley University of Pennsylvania
Surender Khurana
Surender Khurana US Food and Drug Administration
David E. Swayne
David E. Swayne United States Department of Agriculture
Hana Golding
Hana Golding US Food and Drug Administration
Michael S. Diamond
Michael S. Diamond Washington University in St. Louis
Bin Zhang
Bin Zhang Icahn School of Medicine at Mount Sinai

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various specialized healthcare careers, including advanced nursing roles that intersect with immune system-related health. For those interested in mental health and immunology’s role in psychiatric conditions, exploring the cheapest psychiatric nurse practitioner programs can be a cost-effective way to enter this impactful field.

Many professionals pursue a Doctorate in Nursing Practice to deepen their expertise, and understanding the doctorate in nursing salary can help set realistic financial goals after graduation. These programs often prepare students for specialized roles that deal with immune-related diseases and patient care.

Transitioning from a Family Nurse Practitioner to more intensive roles, such as acute care, is possible through targeted education. The guide on acute care nurse practitioner programs outlines the steps needed to make this shift, which can complement immunology knowledge by focusing on patients with critical immune system challenges.

For those looking to accelerate their career timeline, accelerated NP programs offer faster routes to nurse practitioner credentials, allowing quicker application of immunological expertise in clinical settings. These pathways illustrate the intersection of immunology with advanced nursing education and career development.

Best Scientists Citing Ted M. Ross

Trending Scientists

Recently Published Articles